CATi and IL-6 measurement at admission and the use of a composite score could help physicians to better identify such patients with a potentially severe and lethal course, irrespective of obesity and consider early preventive anti-inflammatory therapies. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.